Your browser doesn't support javascript.
loading
Preclinical study of a DNA vaccine targeting SARS-CoV-2.
Hayashi, Hiroki; Sun, Jiao; Yanagida, Yuka; Otera, Takako; Kubota-Koketsu, Ritsuko; Shioda, Tatsuo; Ono, Chikako; Matsuura, Yoshiharu; Arase, Hisashi; Yoshida, Shota; Nakamaru, Ryo; Ju, Nan; Ide, Ryoko; Tenma, Akiko; Kawabata, Sotaro; Ehara, Takako; Sakaguchi, Makoto; Tomioka, Hideki; Shimamura, Munehisa; Okamoto, Sachiko; Amaishi, Yasunori; Chono, Hideto; Mineno, Junichi; Komatsuno, Takao; Saito, Yoshimi; Rakugi, Hiromi; Morishita, Ryuichi; Nakagami, Hironori.
Afiliación
  • Hayashi H; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Japan.
  • Sun J; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Japan.
  • Yanagida Y; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Japan.
  • Otera T; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Japan; Anges Inc, Japan.
  • Kubota-Koketsu R; Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Japan; Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Suita, Japan.
  • Shioda T; Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Japan.
  • Ono C; Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Suita, Japan; Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Matsuura Y; Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Suita, Japan; Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Arase H; Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Japan; Laboratory of Immunochemistry, WPI Immunology Frontier Research Centre, Osaka University, Japan.
  • Yoshida S; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Japan; Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Japan.
  • Nakamaru R; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Japan; Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Japan.
  • Ju N; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Japan; Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Japan.
  • Ide R; FunPep Co., Ltd, Japan.
  • Tenma A; FunPep Co., Ltd, Japan.
  • Kawabata S; FunPep Co., Ltd, Japan.
  • Ehara T; FunPep Co., Ltd, Japan.
  • Sakaguchi M; FunPep Co., Ltd, Japan.
  • Tomioka H; FunPep Co., Ltd, Japan.
  • Shimamura M; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Japan.
  • Okamoto S; Takara Bio Inc., Shiga, Japan.
  • Amaishi Y; Takara Bio Inc., Shiga, Japan.
  • Chono H; Takara Bio Inc., Shiga, Japan.
  • Mineno J; Takara Bio Inc., Shiga, Japan.
  • Komatsuno T; Anges Inc, Japan.
  • Saito Y; Anges Inc, Japan.
  • Rakugi H; Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Japan.
  • Morishita R; Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Japan.
  • Nakagami H; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Japan; Lead contact, Japan. Electronic address: nakagami@gts.med.osaka-u.ac.jp.
Curr Res Transl Med ; 70(4): 103348, 2022 09.
Article en En | MEDLINE | ID: mdl-35489099

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas Virales / Vacunas de ADN / COVID-19 Límite: Humans Idioma: En Revista: Curr Res Transl Med Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas Virales / Vacunas de ADN / COVID-19 Límite: Humans Idioma: En Revista: Curr Res Transl Med Año: 2022 Tipo del documento: Article País de afiliación: Japón
...